Details for: COLY-MYCIN M PARENTERAL
Company: ERFA CANADA 2012 INC
DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
---|---|---|---|---|---|
00476420 | COLY-MYCIN M PARENTERAL | COLISTIN (COLISTIMETHATE SODIUM) | 150 MG / VIAL | POWDER FOR SOLUTION | INTRAMUSCULAR |
00476420 | COLY-MYCIN M PARENTERAL | COLISTIN (COLISTIMETHATE SODIUM) | 150 MG / VIAL | POWDER FOR SOLUTION | INTRAVENOUS |
Consumer Information
This information was provided by the drug’s manufacturer when this drug product was approved for sale in Canada. It is designed for consumers and care givers. It is a summary of information about the drug and will not tell you everything about the drug. Contact your doctor or pharmacist if you have any questions about the drug.
What the medication is used for
COLY-MYCIN* M PARENTERAL is used to treat infections:
- that are sudden and severe
- or are chronic
- caused by certain bacteria
- that are proven or strongly suspected to be caused by certain bacteria
Antibacterial drugs like COLY-MYCIN* M PARENTERAL treat only bacterial infections. They do not treat viral infections. Although you may feel better early in treatment, COLY-MYCIN* M PARENTERAL should be used exactly as directed. Misuse or overuse of COLY-MYCIN* M PARENTERAL could lead to the growth of bacteria that will not be killed by COLY-MYCIN* M PARENTERAL (resistance). This means that COLY-MYCIN* M PARENTERAL may not work for you in the future.
What it does
COLY-MYCIN* M PARENTERAL is an antibiotic that kills bacteria in your body by damaging the cell wall of the bacteria.
When it should not be used
- are allergic or you have a sensitivity to this medicine
- are pregnant.
What the medicinal ingredient is
Medicinal ingredients: colistin (as colistimethate sodium).
What the non-medicinal ingredients are
Non-medicinal ingredients: none.
What dosage form it comes in
As a sterile powder for solution in a vial containing 150 mg colistin.
Warnings and precautions
- have kidney problems.
Other warnings you should know about:
COLY-MYCIN* M PARENTERAL may cause dizziness or light-headedness. Do not drive or use machines while you are receiving this medicine.
Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.
Interactions with this medication
- Other antibiotics such as kanamycin, streptomycin, dihydrostreptomycin, polymyxin, and neomycin.
- Muscle relaxants such as ether, tubocurarine, succinylcholine, gallamine, decamethonium and sodium citrate. These should be used with extreme caution.
Proper use of this medication
- COLY-MYCIN* M PARENTERAL will be given to you by a healthcare professional
- It will either be infused directly into your vein or;
- It will be injected into your muscle.
- Follow all instructions given to you by your healthcare professional.
Usual dose
- Your healthcare professional will decide how much COLY-MYCIN* M PARENTERAL you will receive.
- You will receive it 2, 3 or 4 times a day.
- Your healthcare professional will decide how often and for how long you will receive COLY-MYCIN* M PARENTERAL.
Overdose
Overdosage can result in kidney problems, muscle weakness and difficulty breathing.
Side effects and what to do about them
These are not all the possible side effects you may feel when taking COLY-MYCIN* M PARENTERAL. If you experience any side effects not listed here, contact your healthcare professional.
Side effects may include:
- dizziness or vertigo (light-headedness)
- tingling of the tongue
- itching of the skin
- hives
- fever
- nausea and vomiting
- upset stomach
- diarrhea
Symptom / effect | Talk to your healthcare professional Only if severe | Talk to your healthcare professional In all cases | Stop taking drug and get immediate medical help |
---|---|---|---|
RARE | |||
Breathing difficulty, breathing stops | ✔ | ||
Kidney problems: abdominal or back pain, dark urine, decreased urination, nausea, swelling of the arms or legs, vomiting, weakness | ✔ | ||
Slow or slurred speech | ✔ | ||
Tingling, prickling, numbness or burning of hands or feet or around the mouth | ✔ |
If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional.
How to store
- Store COLY-MYCIN* M PARENTERAL at room temperature (15 to 30°C).
- After reconstitution, refrigerate COLY-MYCIN M PARENTERAL solution (2 to 8°C) and use within 3 days.
- Reconstituted COLY-MYCIN* M PARENTERAL solution can also be stored at room temperature (15 to 30°C) and must be used within 24 hours.
- Infusion solution containing COLY-MYCIN* M PARENTERAL should be freshly prepared and used within 24 hours.
Keep out of reach and sight of children.
Reporting side effects
You can report any suspected side effects associated with the use of health products to Health Canada by:
- Visiting the Web page on Adverse Reaction Reporting http://www.hc-sc.gc.ca/dhp-mps/medeff/report-declaration/index-eng.phpfor information on how to report online, by mail or by fax; or
- Calling toll-free at 1-866-234-2345.
NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.
More information
- Talk to your healthcare professional
- Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website(http://hc-sc.gc.ca/index-eng.php); the manufacturer's website (www.eci2012.net), or by calling 1-800-931-3133.
This leaflet was prepared by ERFA Canada 2012 Inc.
Last Revised January 4, 2018